<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30146">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01956617</url>
  </required_header>
  <id_info>
    <org_study_id>2013/1328-3</org_study_id>
    <nct_id>NCT01956617</nct_id>
  </id_info>
  <brief_title>The Mininimum Effective Anaesthetic Volume of Local Anaesthetic in Ultrasound-guided &quot;Shamrock&quot; Lumbar Plexus Block</brief_title>
  <official_title>The Mininimum Effective Anaesthetic Volume of Local Anaesthetic in Ultrasound-guided &quot;Shamrock&quot; Lumbar Plexus Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The &quot;Shamrock method&quot; is a new ultrasound-guided lumbar plexus block. The aim of the study
      is to determine the minimum effective volume of ropivacaine 0.5% required to produce an
      effective lumbar plexus block with this method. Using the Dixon and Massey up-and-down
      method study design, 30 patients scheduled for elective total hip and knee arthroplasty will
      be included in the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>minimum effective volume</measure>
    <time_frame>from day 1 up to 20 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>The primary outcome measure (MEV) is based on 30 measurements in 30 patients (secondary outcome measure: block success). MEV is determined by Dixon and Massey up-and-down method when all patients have been tested in the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>block success</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>45 minutes after lumbar plexus blockade was performed</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Mininimum Effective Anaesthetic Volume of Local Anaesthetic</condition>
  <arm_group>
    <arm_group_label>injection volume</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>block success or failure determines a 5 ml decrease or increase for the subsequent patient, respectively</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>lumbar plexus block</intervention_name>
    <arm_group_label>injection volume</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  orthopaedic patients scheduled for elective hip and knee arthoroplasty

          -  ASA 1 - 2 or stable ASA 3

          -  age between 18 and 70 years

          -  good ability to communicate and to cooperate

        Exclusion Criteria:

          -  ASA &gt; 3 or unstable ASA 3

          -  BMI &gt; 32

          -  chronicle pain

          -  nephrological diseases or nephropathy

          -  known contraindications against the use of local anaesthetics

          -  pregnancy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Axel R Sauter, MD, PhD</last_name>
    <phone>23073700</phone>
    <phone_ext>+47</phone_ext>
    <email>sauter@start.no</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0488</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Axel R Sauter, MD, PhD</last_name>
      <phone>23073700</phone>
      <phone_ext>+47</phone_ext>
      <email>sauter@start.no</email>
    </contact>
    <investigator>
      <last_name>Axel R Sauter, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kyrre Ullensvang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis Romundstad, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department of Anaesthesia and Intensive Care Medicine, Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0027</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel R Sauter, MD, PhD</last_name>
      <phone>23073700</phone>
      <phone_ext>+47</phone_ext>
      <email>sauter@start.no</email>
    </contact>
    <investigator>
      <last_name>Axel R Sauter, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <link>
    <url>http://bja.oxfordjournals.org/forum/topic/brjana_el%3b9814</url>
    <description>The &quot;shamrock method&quot; was described as e-letter in BJA</description>
  </link>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 16, 2013</lastchanged_date>
  <firstreceived_date>September 26, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Axel Rudolf Sauter</investigator_full_name>
    <investigator_title>MD. PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics, Local</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
